|
Market Closed -
NYSE
01:30:02 14/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 45.55 USD | +0.42% |
|
-3.76% | +12.19% |
| 21/09 | Avantor Names Todd Garner as CFO | MT |
| 05/09 | CONMED Corporation Announces Voluntary Recall of Genesys Crossft Suture Anchor | CI |
| Market Cap | 136.43Cr 121.84Cr 113.6Cr 102.93Cr 193.97Cr 13TCr 195.39Cr 1.36TCr 531.86Cr 6.73TCr 512.36Cr 501.07Cr 22TCr | P/E 2026 * |
11.7x | P/E 2027 * | 10.1x |
|---|---|---|---|---|---|
| Enterprise Value | 210.57Cr 188.06Cr 175.34Cr 158.87Cr 299.4Cr 20TCr 301.58Cr 2.1TCr 820.92Cr 10TCr 790.81Cr 773.4Cr 33TCr | EV / Sales 2026 * |
1.54x | EV / Sales 2027 * | 1.4x |
| Free-Float |
95.39% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| CNMD | Delayed | |
CBOE
| CNMD | Real-time | |
|
Deutsche Boerse AG
| EC8 | Delayed | |
|
Tradegate
| EC8 | Real-time | |
|
Börse Stuttgart
| EC8 | Delayed | |
|
Boerse Muenchen
| EC8 | Real-time | |
|
Berne S.E.
| EC8 | End-of-day quote |
Last Transcript: CONMED Corporation
| 1 day | +0.42% | ||
| 1 week | -3.76% | ||
| Current month | -1.47% | ||
| 1 month | -1.62% | ||
| 3 months | +18.37% | ||
| 6 months | +23.98% | ||
| Current year | +12.19% |
| 1 week | 43.97 |  | 46.09 |
| 1 month | 43.97 | | 48.25 |
| Current year | 31.44 | | 53.66 |
| 1 year | 31.44 | | 53.66 |
| 3 years | 31.44 | | 117.27 |
| 5 years | 31.44 | | 159.11 |
| 10 years | 31.44 | | 159.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Patrick Beyer
CEO | Chief Executive Officer | 60 | 01/01/2025 |
John Gallagher
DFI | Director of Finance/CFO | 53 | 15/07/2026 |
Brent Lalomia
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Farkas
BRD | Director/Board Member | 74 | 23/07/2014 |
Patrick Beyer
BRD | Director/Board Member | 60 | 01/01/2025 |
David Bronson
BRD | Director/Board Member | 72 | 01/07/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/09/26 | Exercice | Director | 1,000 | 0.0033% | ||
| 15/07/26 | Other | Chief Financial Officer | 0 | 0% | ||
| 15/07/26 | Free | Chief Financial Officer | 92,465 | 0.3071% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.42% | -3.76% | +6.72% | -50.11% | 135.86Cr | |
| +0.78% | +2.51% | -22.60% | +13.77% | 18TCr | |
| +1.17% | +5.73% | -2.56% | +30.47% | 12TCr | |
| -0.02% | -0.94% | -22.50% | +11.31% | 11TCr | |
| -0.31% | +1.25% | -46.49% | -12.10% | 7.53TCr | |
| +1.55% | +4.82% | +3.81% | +75.99% | 6.2TCr | |
| +1.04% | +3.33% | +16.26% | +62.38% | 5.28TCr | |
| -0.80% | +3.71% | +0.43% | -27.11% | 5.15TCr | |
| -0.69% | -1.28% | -15.55% | +21.48% | 4.13TCr | |
| -0.17% | -0.28% | - | - | 3.14TCr | |
| Average | +0.30% | +1.50% | -9.16% | +14.01% | 7.18TCr | |
| Weighted average by Cap. | +0.45% | +2.14% | -14.19% | +20.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 136.65Cr 122.04Cr 113.79Cr 103.1Cr 194.3Cr 13TCr 195.72Cr 1.36TCr 532.75Cr 6.74TCr 513.21Cr 501.9Cr 22TCr | 143.37Cr 128.04Cr 119.38Cr 108.17Cr 203.84Cr 14TCr 205.33Cr 1.43TCr 558.91Cr 7.08TCr 538.41Cr 526.56Cr 23TCr |
| Net income | 12Cr 10Cr 9.72Cr 8.8Cr 17Cr 1.11TCr 17Cr 116.19Cr 45Cr 575.97Cr 44Cr 43Cr 1.85TCr | 13Cr 12Cr 11Cr 10Cr 19Cr 1.29TCr 19Cr 134.4Cr 53Cr 666.22Cr 51Cr 50Cr 2.14TCr |
| Net Debt | 74Cr 66Cr 62Cr 56Cr 105.42Cr 7.06TCr 106.19Cr 738.24Cr 289.06Cr 3.66TCr 278.46Cr 272.32Cr 12TCr | 64Cr 57Cr 53Cr 48Cr 91Cr 6.08TCr 91Cr 635.16Cr 248.7Cr 3.15TCr 239.58Cr 234.3Cr 10TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | $45.55 | +0.42% | 5,21,525 |
| 12/26/12 | $45.36 | +2.12% | 5,15,221 |
| 09/26/09 | $44.42 | -1.53% | 4,00,451 |
| 08/26/08 | $45.11 | +1.99% | 4,73,961 |
| 07/26/07 | $44.23 | -0.56% | 5,21,294 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CNMD Stock
Select your edition
All financial news and data tailored to specific country editions
